A.S. Melo, R.A. Ferriani, P.A. Navarro, Treatment of infertility in women with polycystic ovary syndrome: approach to clinical practice. Clinics 70, 765–769 (2015)
Article PubMed PubMed Central Google Scholar
A.H. Balen, L.C. Morley, M. Misso, S. Franks, R.S. Legro, C.N. Wijeyaratne, E. Stener-Victorin, B.C. Fauser, R.J. Norman, H. Teede, The management of anovulatory infertility in women with polycystic ovary syndrome: an analysis of the evidence to support the development of global WHO guidance. Hum. Reprod. Update 22(6), 687–708 (2016)
U. Zafar, Z. Memon, K. Moin, S. Agha, J.A. Hassan, D. Zehra, Prevalence of PCOS with associated symptoms and complications at Tertiary Care Hospital of Karachi. J. Adv. Med. Med. Res. 30(4), 1–9 (2019)
A.Z. Rutkowska, E. Diamanti-Kandarakis, Polycystic ovary syndrome and environmental toxins. Fertil. Steril. 106(4), 948–958 (2016)
Article CAS PubMed Google Scholar
Rotterdam ESHRE/ASRM‐Sponsored PCOS Consensus Workshop Group, Revised 2003 consensus on diagnostic criteria and long‐term health risks related to polycystic ovary syndrome (PCOS). Hum. Reprod. 19(1), 41–47 (2004)
J. Liu, Q. Wu, Y. Hao, M. Jiao, X. Wang, S. Jiang, L. Han, Measuring the global disease burden of polycystic ovary syndrome in 194 countries: Global Burden of Disease Study 2017. Hum. Reprod. 36(4), 1108–19. (2021)
Article PubMed PubMed Central Google Scholar
M. Peigné, D. Dewailly, Long term complications of polycystic ovary syndrome (PCOS). In Annales d’endocrinologie (2014) (Vol. 75, No. 4, pp. 194–199). Elsevier Masson
R. Azziz, C. Marin, L. Hoq, E. Badamgarav, P. Song, Health care-related economic burden of the polycystic ovary syndrome during the reproductive life span. J. Clin. Endocrinol. Metab. 90(8), 4650–4658 (2005)
Article CAS PubMed Google Scholar
C. Meng, Nitric oxide (NO) levels in patients with polycystic ovary syndrome (PCOS): a meta-analysis. J. Int. Med. Res. 47(9), 4083–94. (2019).
Article CAS PubMed PubMed Central Google Scholar
W.M. Wolf, R.A. Wattick, O.N. Kinkade, M.D. Olfert, Geographical prevalence of polycystic ovary syndrome as determined by region and race/ethnicity. Int. J. Environ. Res. public health 15(11), 2589 (2018)
Article PubMed Central Google Scholar
S. Li, D. Zhu, H. Duan, Q. Tan, Genetic investigation into ethnic disparity in polycystic ovarian syndrome. Gynecol. Endocrinol. 29(10), 878–882 (2013)
S. Brakta, D. Lizneva, K. Mykhalchenko, A. Imam, W. Walker, M.P. Diamond, R. Azziz, Perspectives on polycystic ovary syndrome: is polycystic ovary syndrome research underfunded? J. Clin. Endocrinol. Metab. 102(12), 4421–4427 (2017)
E. Kandaraki, A. Chatzigeorgiou, C. Piperi, E. Palioura, S. Palimeri, P. Korkolopoulou, M. Koutsilieris, A.G. Papavassiliou, Reduced ovarian glyoxalase-I activity by dietary glycotoxins and androgen excess: a causative link to polycystic ovarian syndrome. Mol. Med. 18(8), 1183–1189 (2012)
Article CAS PubMed PubMed Central Google Scholar
P. Moghetti, Insulin resistance and polycystic ovary syndrome. Curr. Pharm. Des. 22(36), 5526–5534 (2016). https://doi.org/10.2174/1381612822666160720155855
Article CAS PubMed Google Scholar
E. Diamanti-Kandarakis, A.G. Papavassiliou, Outstanding questions. Trends Mol. Med. 7(12), 324–32. (2006)
F.K.H. Shirazi, Z. Khodamoradi, M. Jeddi, Insulin resistance and high molecular weight adiponectin in obese and non-obese patients with Polycystic Ovarian Syndrome (PCOS).BMC Endocr. Disord. 21, 45 (2021). :https://doi.org/10.1186/s12902-021-00710-z
Article CAS PubMed PubMed Central Google Scholar
L. Ibanez, E. Oberfield Sh, S.F. Witchel, R.J. Auchus, R.J. Chang, E. Codner et al. An international consortium apdate: pathophysiology, diagnosis, and treatment of polycystic ovarian syndrome in adolescence. Horm. Res. Paediatr. 8896, 371–395 (2017).
N.E. Baskind, A.H. Balen, Hypothalamic–pituitary, ovarian and adrenal contributions to polycystic ovary syndrome. Best. Pract. Res. Clin. Obstet. Gynaecol. 37, 80–97 (2016)
N.M. Orsi, N.E. Baskind, M. Cummings, Anatomy, development, histology, and normal function of the ovary. in Pathology of the Ovary, Fallopian Tube and Peritoneum, (Springer, London, 2014) pp. 1–32.
A.M. Moore, R.E. Campbell, The neuroendocrine genesis of polycystic ovary syndrome: a role for arcuate nucleus GABA neurons. J. Steroid Biochem. Mol. Biol. 160, 106–117 (2016)
Article CAS PubMed Google Scholar
J.E. Hall, A.E. Taylor, F.J. Hayes, W.F. Crowley, Insights into hypothalamic-pituitary dysfunction in polycystic ovary syndrome. J. Endocrinol. Investig. 21(9), 602–611 (1998).
D. Barlampa, M.S. Bompoula, A. Bargiota, S. Kalantaridou, G. Mastorakos, G. Valsamakis, Hypothalamic inflammation as a potential pathophysiologic basis for the heterogeneity of clinical, hormonal, and metabolic presentation in PCOS. Nutrients 13(2), 520 (2021)
Article CAS PubMed PubMed Central Google Scholar
K.S. Olaniyi, A.A. Oniyide, O.A. Adeyanju, L.S. Ojulari, A.O. Omoaghe, O.E. Olaiya, Low dose spironolactone-mediated androgen-adiponectin modulation alleviates endocrine-metabolic disturbances in letrozole-induced PCOS. Toxicol. Appl. Pharmacol. 411, 115381 (2021a)
Article CAS PubMed Google Scholar
A.P. Delitala, G. Capobianco, G. Delitala, P.L. Cherchi, S. Dessole, Polycystic ovary syndrome, adipose tissue and metabolic syndrome. Arch. Gynecol. Obstet. 296(3), 405–419 (2017)
Article CAS PubMed Google Scholar
P.M. Spritzer, S.B. Lecke, F. Satler, D.M. Morsch, Adipose tissue dysfunction, adipokines, and low-grade chronic inflammation in polycystic ovary syndrome. Reproduction 149(5), R219–R227 (2015)
Article CAS PubMed Google Scholar
R. Pasquali, Lifestyle Interventions and Natural and Assisted Reproduction in Patients with PCOS. InInfertility in Women with Polycystic Ovary Syndrome 2018 (pp. 169–180). Springer, Cham
B. Zeng, Z. Lai, L. Sun, Z. Zhang, J. Yang, Z. Li, J. Lin, Z. Zhang, Structural and functional profiles of the gut microbial community in polycystic ovary syndrome with insulin resistance (IR-PCOS): a pilot study. Res. Microbiol. 170(1), 43–52 (2019)
Article CAS PubMed Google Scholar
L.G. Silveira, C. Tusset, A.C. Latronico, Impact of mutations in kisspeptin and neurokinin B signaling pathways on human reproduction. Brain Res. 1364, 72–80 (2010)
Article CAS PubMed Google Scholar
B.S. Araújo, M.C. Baracat, R. dos Santos Simões, C. de Oliveira Nuñes, G.A. Maciel, R.A. Lobo, J.M. Soares-Jr, E.C. Baracat, Kisspeptin Influence on Polycystic Ovary Syndrome—A Mini Review. Reprod. Sci. 27(2), 455–460 (2020)
R.E. Brown, D.A. Wilkinson, S.A. Imran, A. Caraty, M. Wilkinson, Hypothalamic kiss1 mRNA and kisspeptin immunoreactivity are reduced in a rat model of polycystic ovary syndrome (PCOS). Brain Res. 1467, 1–9 (2012).
Article CAS PubMed Google Scholar
S. Osuka, A. Iwase, T. Nakahara, M. Kondo, A. Saito, T. Nakamura, S. Takikawa, M. Goto, T. Kotani, F. Kikkawa, Kisspeptin in the hypothalamus of 2 rat models of polycystic ovary syndrome. Endocrinology 158(2), 367–377 (2017).
J.C. Venancio, L.O. Margatho, R. Rorato, R.R. Rosales, L.K. Debarba, R. Coletti, J. Antunes-Rodrigues, C.F. Elias, L.L. Elias, Short-term high-fat diet increases leptin activation of CART neurons and advances puberty in female mice. Endocrinology 158(11), 3929–3942 (2017)
Article CAS PubMed PubMed Central Google Scholar
C.Y. Lee, S. Li, X.F. Li, D.A. Stalker, C. Cooke, B. Shao, H. Kelestimur, B.A. Henry, G. Conductier, K.T. O’Byrne, I.J. Clarke, Lipopolysaccharide reduces gonadotrophin-releasing hormone (GnRH) gene expression: Role of RFamide-related peptide-3 and kisspeptin. Reprod., Fertil. Dev. 31(6), 1134–1143 (2019)
M.A. González Hernández, E.E. Canfora, J.W. Jocken, E.E. Blaak, The short-chain fatty acid acetate in body weight control and insulin sensitivity. Nutrients 11(8), 1943 (2019)
Article PubMed Central Google Scholar
K.S. Olaniyi, O.A. Amusa, Sodium acetate-mediated inhibition of histone deacetylase alleviates hepatic lipid dysregulation and its accompanied injury in streptozotocin-nicotinamide-induced diabetic rats. Biomedicine Pharmacother. 128, 110226 (2020)
V. Karoor, D. Strassheim, T. Sullivan, A. Verin, N.S. Umapathy, E.C. Dempsey, D.N. Frank, K.R. Stenmark, E. Gerasimovskaya, The short-chain fatty acid butyrate attenuates pulmonary vascular remodeling and inflammation in hypoxia-induced pulmonary hypertension. Int. J. Mol. Sci. 22(18), 9916 (2021)
Article CAS PubMed PubMed Central Google Scholar
O.A. Adeyanju, T.O. Falodun, O.S. Michael, O.A. Soetan, A.L. Oyewole, R.D. Agbana, Spironolactone reversed hepato-ovarian triglyceride accumulation caused by letrozole-induced polycystic ovarian syndrome: tissue uric acid—a familiar foe. Naunyn-Schmiedeberg’s Arch. Pharmacol. 393(6), 1055–1066 (2020).
H. Kafali, M. Iriadam, I. Ozardali, N. Demir, Letrozole-induced polycystic ovaries in the rat: a new model for cystic ovarian disease. Arch. Med. Res. 35, 103–108 (2004)
Article CAS PubMed Google Scholar
K.S. Olaniyi, M.N. Owolabi, C.L. Atuma, T.B. Agunbiade, B.Y. Alabi, Acetate rescues defective brain-adipose metabolic network in obese Wistar rats by modulation of peroxisome proliferator-activated receptor-γ. Sci. Rep. 11(1), 1–5 (2021b)
留言 (0)